Clinical trial
A Phase 2 Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to Evaluate Oral Ifetroban in Subjects With Symptomatic Aspirin Exacerbated Respiratory Disease (AERD)
NCT03028350 is registered in ClinicalTrials.gov with Cumberland Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to Evaluate Oral Ifetroban in Subjects With Symptomatic Aspirin Exacerbated Respiratory Disease (AERD)
- Lead sponsor
- Cumberland Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 17, 2017
- Completion date
- April 25, 2023
- Enrollment
- 54 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.